Clinical Trial

Safety and User Experience of BP-CBB

Recruiting
View on ClinicalTrials.gov →
Summary
This study is the first-in human study for the food ingredient BP-CBB and aims aims to build on the excellent safety and tolerability observed in the extensive food safety assessment performed for BP-CBB, as well as the consumer experience with using the product, and to set the scene for future human studies documenting the health-benefits of daily supplementation with BP-CBB for diverse populations.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-19
Trial Details
NCT Number NCT07628608
Lead Sponsor Bactolife A/S
Collaborators: Atlantia Food Clinical Trials
Conditions Safety and Tolerability in Healthy Volunteers
Enrollment 60 participants
Start Date 2026-06-16
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-18